Morning Buzz: Immunomedics (IMMU), SunPower (SPWR), Amedica Corp (AMDA), Progenics Pharma (PGNX)

Immunomedics Inc. (IMMU) is one of today’s notable stocks in decline, down as much as 45 percent following Belgium’s UCB announcement that its Phase 3 clinical trial program for Epratuzumab did not meet primary endpoint. Epratuzumab was licensed from Immunomedics. “Although we are disappointed with the results from the Phase 3 program, our commitment to […] View the full post at: Morning Buzz: Immunomedics (IMMU), SunPower (SPWR), Amedica Corp (AMDA), Progenics Pharma (PGNX) Related posts: SunPower Shows Solar Can Be Profitable Accounting Irregularities Eclipse SunPower Apache Corp. in final talks to buy Energy Corp’s shallow Gulf assets